TREM2 and neoplasm: Immunohistochemistry on tumour biopsy specimens before CAR T‐cell infusion revealed elevated levels of CD163+ and TREM2+ cells in non‐responders compared to responders (p = .0092 and p = .0350, respectively; Figure 4B).